Connable Office Inc Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Connable Office Inc reduced its stake in Stryker Corporation by 0.27% during the most recent quarter end. The investment management company now holds a total of 34,818 shares of Stryker Corporation which is valued at $3,861,664 after selling 95 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on May 9, 2016.Stryker Corporation makes up approximately 1.07% of Connable Office Inc’s portfolio.

Other Hedge Funds, Including , Investors Capital Advisory Services reduced its stake in SYK by selling 18 shares or 0.48% in the most recent quarter. The Hedge Fund company now holds 3,745 shares of SYK which is valued at $415,358. Stryker Corporation makes up approx 0.08% of Investors Capital Advisory Services’s portfolio. Ausdal Financial Partners sold out all of its stake in SYK during the most recent quarter. The investment firm sold 82 shares of SYK which is valued $9,119.Thompson Davis reduced its stake in SYK by selling 132 shares or 26.19% in the most recent quarter. The Hedge Fund company now holds 372 shares of SYK which is valued at $41,370. Stryker Corporation makes up approx 0.06% of Thompson Davis’s portfolio.Retirement Systems Of Alabama reduced its stake in SYK by selling 4,376 shares or 2.67% in the most recent quarter. The Hedge Fund company now holds 159,409 shares of SYK which is valued at $17,377,175. Stryker Corporation makes up approx 0.10% of Retirement Systems Of Alabama’s portfolio. Quantbot Technologies Lp sold out all of its stake in SYK during the most recent quarter. The investment firm sold 18,688 shares of SYK which is valued $2,037,179.

Stryker Corporation closed down -0.91 points or -0.81% at $110.91 with 10,50,700 shares getting traded on Friday. Post opening the session at $111.91, the shares hit an intraday low of $110.41 and an intraday high of $112.01 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.